Breaking News Instant updates and real-time market news.

2022-05-09 06:05:25 SNCE Science 37 $3.55 / -0.18 (-4.83%) 06:05 05/09/22 05/09 06:05 05/09/22 06:05	Science 37 backs 2022 revenue view $86M-$96M, consensus $91.13M Sees 2022 adjusted EBITDA ($65M)-($69M).	09 May 13 May

2022-05-09 06:05:25

SNCE

Science 37

$3.55 / -0.18 (-4.83%)

06:05

05/09/22

05/09

06:05

05/09/22

06:05

Science 37 backs 2022 revenue view $86M-$96M, consensus $91.13M

Sees 2022 adjusted EBITDA ($65M)-($69M).

09
May
13
May

OTHER BREAKING NEWS FROM THE FLY

Recommendations	Inspirato price target lowered to $7 from $9 at Piper Sandler » 18:38 08/08/22 08/08 18:38 08/08/22 18:38 ISPO Inspirato $4.93 / -0.11 (-2.18%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options ISPO Inspirato $4.93 / -0.11 (-2.18%) 06/09/22 Inspirato announces Inspirato Select subscription 04/21/22 Tang Capital reports 5.0% passive stake in Inspirato 04/18/22 Inspirato announces 11 new luxury residences at 71 Wentworth 04/11/22 Inspirato announces 2023 luxury cruise program ISPO Inspirato $4.93 / -0.11 (-2.18%) 07/22/22 Cantor Fitzgerald Inspirato assumed with a Neutral at Cantor Fitzgerald 06/28/22 Stifel Inspirato price target lowered to $6 from $7 at Stifel 06/14/22 Oppenheimer Inspirato initiated with a Perform at Oppenheimer 05/20/22 Evercore ISI Inspirato initiated with an In Line at Evercore ISI ISPO Inspirato $4.93 / -0.11 (-2.18%) 07:34 Today Inspirato reports Q2 EPS (6c) vs (1c) last year 05/11/22 Inspirato sees FY22 revenue $350M-$360M, consensus $354.13M 05/11/22 Inspirato reports Q1 EPS (26c), consensus (47c) ISPO Inspirato $4.93 / -0.11 (-2.18%) 06/14/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/11/22 Fly Intel: After-Hours Movers 04/21/22 Fly Intel: After-Hours Movers 11:00 Today Inspirato - ISPO ISPO Inspirato $4.93 / -0.11 (-2.18%) 07/11/22 Largest borrow rate increases among liquid names 07/07/22 Largest borrow rate increases among liquid names 05/11/22 Inspirato options imply 7.9% move in share price post-earnings 05/11/22 Largest borrow rate increases among liquid names
Periodicals	BP begins drilling appraisal well in Texas, Reuters reports » 18:33 08/08/22 08/08 18:33 08/08/22 18:33 BP BP $30.17 / +0.515 (+1.74%) Jack Collins, finance… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BP BP $30.17 / +0.515 (+1.74%) 07:56 Today Cenovus Energy acquiring 50% interest in Toledo refinery from BP 08/03/22 FleetCor extends BP relationship 08/02/22 BP bosts dividend 10%, announces further $3.5B share buyback 08/02/22 BP announces further $3.5B share buyback BP BP $30.17 / +0.515 (+1.74%) 14:08 Today Berenberg BP price target lowered to 500 GBp from 510 GBp at Berenberg 07/20/22 HSBC BP price target lowered to 430 GBp from 455 GBp at HSBC 07/19/22 Piper Sandler BP price target raised to $44 from $42 at Piper Sandler 07/15/22 JPMorgan BP price target raised to 530 GBp from 500 GBp at JPMorgan BP BP $30.17 / +0.515 (+1.74%) 08/02/22 BP reports Q2 EPS $2.61, consensus $2.13 05/03/22 BP reports Q1 EPS $1.92, consensus $1.35 BP BP $30.17 / +0.515 (+1.74%) 08/03/22 OPEC+ answers diplomatic efforts with 'minuscule' output hike, Bloomberg says 08/02/22 OPEC+ sees slightly smaller oil market surplus in 2022, Reuters reports 07/14/22 BP looking to make sustainable aviation fuel in Australia by 2025, Reuters says 07/06/22 OPEC Secretary-General Mohammad Barkindo dies, Bloomberg reports BP BP $30.17 / +0.515 (+1.74%) 08/02/22 What You Missed On Wall Street On Tuesday 08/02/22 What You Missed On Wall Street This Morning 07/14/22 What You Missed On Wall Street This Morning 07/01/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations BP BP $30.17 / +0.515 (+1.74%) 08/05/22 Unusually active option classes on open August 5th 08/04/22 BP call volume above normal and directionally bullish 08/02/22 Unusually active option classes on open August 2nd 07/05/22 Unusually active option classes on open July 5th
Hot Stocks	Oshkosh CEO: We have a record backlog » 18:25 08/08/22 08/08 18:25 08/08/22 18:25 OSK Oshkosh $83.99 / +0.76 (+0.91%) In an interview on… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly OSK Oshkosh $83.99 / +0.76 (+0.91%) 06/30/22 Oshkosh awarded $216.73M Army contract modification 06/13/22 Oshkosh completes acquisition of Maxi-Metal 05/06/22 Oshkosh to increase share repurchase authorization by 8M shares 05/06/22 Oshkosh announces FY25 targets ahead of investor day OSK Oshkosh $83.99 / +0.76 (+0.91%) 07/28/22 Baird Oshkosh price target lowered to $83 from $84 at Baird 07/26/22 Argus Argus starts Oshkosh at Hold on near-term inflation and supply chain challenges 07/26/22 Argus Oshkosh initiated with a Hold at Argus 07/13/22 Deutsche Bank Oshkosh price target lowered to $101 from $118 at Deutsche Bank OSK Oshkosh $83.99 / +0.76 (+0.91%) 07/28/22 Oshkosh reports Q2 EPS 41c, consensus 90c 04/28/22 Environmental groups, state AGs sue to block Postal Service truck order 04/27/22 Oshkosh lowers FY22 EPS view to $5-$6, consensus $6.22 04/27/22 Oshkosh reports Q1 EPS 24c, consensus 16c OSK Oshkosh $83.99 / +0.76 (+0.91%) 07/20/22 USPS now plans more electric delivery vehicles, Reuters says 05/12/22 House panel investigating USPS plan to acquire gas-powered trucks, WP says OSK Oshkosh $83.99 / +0.76 (+0.91%) 07/26/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/12/22 What You Missed On Wall Street On Thursday 02/15/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Hot Stocks	Robinhood exec sells $1.18M in common stock » 18:22 08/08/22 08/08 18:22 08/08/22 18:22 HOOD Robinhood $10.68 / +0.29 (+2.79%) In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options HOOD Robinhood $10.68 / +0.29 (+2.79%) 08/04/22 Robinhood CEO says in 'great position as a stand-alone company' 08/04/22 SEC probing Robinhood compliance with short selling rules 08/02/22 Robinhood sees FY22 operating expenses $1.7B-$1.76B 08/02/22 Robinhood cuts 23% of workforce amid reduced customer activity HOOD Robinhood $10.68 / +0.29 (+2.79%) 08/04/22 Deutsche Bank Robinhood price target raised to $9 from $8 at Deutsche Bank 08/04/22 Mizuho Robinhood price target lowered to $13 from $14 at Mizuho 08/03/22 Piper Sandler Robinhood price target lowered to $10 from $11 at Piper Sandler 07/25/22 JPMorgan JPMorgan sees increased share dilution risk for Coinbase, Robinhood HOOD Robinhood $10.68 / +0.29 (+2.79%) 08/03/22 Notable companies reporting after market close 08/02/22 Robinhood reports Q2 EPS (34c), consensus (37c) 04/28/22 Robinhood reports Q1 EPS (45c), consensus (36c) 04/28/22 Notable companies reporting after market close HOOD Robinhood $10.68 / +0.29 (+2.79%) 07/20/22 Study finds Robinhood cause of phantom surge in Berkshire Hathaway, WSJ reports 06/27/22 Bankman-Fried says FTX not in active M&A talks with Robinhood, WSJ says 06/27/22 FTX deliberating about potential of deal to buy Robinhood, Bloomberg says 06/27/22 FTX deliberating about potential of deal to buy Robinhood, Bloomberg says HOOD Robinhood $10.68 / +0.29 (+2.79%) 08/05/22 Here's What You Missed in Crypto This Week 08/03/22 Fly Intel: After-Hours Movers 08/03/22 What You Missed On Wall Street On Wednesday 08/03/22 What You Missed On Wall Street This Morning HOOD Robinhood $10.68 / +0.29 (+2.79%) 10:25 Today Robinhood Markets call volume above normal and directionally bullish 08/05/22 Unusually active option classes on open August 5th 08/04/22 Robinhood Markets call volume above normal and directionally bullish 08/04/22 Unusually active option classes on open August 4th
Hot Stocks	Corvex Management discloses 5% stake in MDU Resources » 18:12 08/08/22 08/08 18:12 08/08/22 18:12 MDU MDU Resources $29.08 / -0.125 (-0.43%) Corvex Management… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings MDU MDU Resources $29.08 / -0.125 (-0.43%) 08/04/22 MDU Resources to separate Knife River via tax-free spinoff to shareholders 08/04/22 MDU Resources to separate Knife River to create two public companies MDU MDU Resources $29.08 / -0.125 (-0.43%) 08/05/22 BofA MDU Resources downgraded to Neutral from Buy at BofA MDU MDU Resources $29.08 / -0.125 (-0.43%) 08/04/22 MDU Resources now sees FY22 EPS $1.75-$1.90, consensus $2.01 08/04/22 MDU Resources reports Q2 EPS 35c, consensus 51c 05/04/22 MDU Resources backs FY22 EPS view $2.00-$2.15, consensus $2.05 05/04/22 MDU Resources reports Q1 EPS 16c, consensus 21c
Hot Stocks	Bright Scholar to change ratio of its ADSs » 18:02 08/08/22 08/08 18:02 08/08/22 18:02 BEDU Bright Scholar / + Bright Scholar Education… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News BEDU Bright Scholar / + 08/03/22 Bright Scholar completes redemption of remaining outstanding senior notes 04/29/22 Bright Scholar receives preliminary non-binding 'going private' proposal 04/01/22 Bright Scholar receives noncompliance letter from NYSE
Hot Stocks	Pzena Investment reports AUM as of July 31 at $47.2B vs. $45.0B as of June 30 18:00 08/08/22 08/08 18:00 08/08/22 18:00 PZN Pzena Investment $9.49 / + (+0.00%) ShowHide Related Items >><< Company News Earnings On The Fly PZN Pzena Investment $9.49 / + (+0.00%) 07/26/22 Pzena Investment to become private company 06/07/22 Pzena Investment reports AUM as of May 31 $50.7B 06/07/22 Pzena Investment reports AUM as of May 31 $50.7B 05/09/22 Pzena Investment reports preliminary AUM $49.5B at April 30 PZN Pzena Investment $9.49 / + (+0.00%) 04/19/22 Pzena Investment reports Q1 EPS 16c vs 24c YoY PZN Pzena Investment $9.49 / + (+0.00%) 07/26/22 Fly Intel: After-Hours Movers 04/19/22 Fly Intel: After-Hours Movers
Conference/Events	BridgeBio management to meet with BTIG » 17:55 08/08/22 08/08 17:55 08/08/22 17:55 BBIO BridgeBio $11.91 / +0.745 (+6.67%) In conjunction with the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events BBIO BridgeBio $11.91 / +0.745 (+6.67%) 08/04/22 BridgeBio sees expenses, cash burn declining meaningfully in Q3, Q4 07/26/22 BridgeBio announces interim results from Phase 2 trial of infigratinib 07/25/22 BridgeBio and Sentynl receive positive opinion from CHMP for Nulibry 07/25/22 BridgeBio, Sentynl receive positive CHMP opinion for NULIBRY BBIO BridgeBio $11.91 / +0.745 (+6.67%) 08/05/22 JPMorgan BridgeBio selloff on Alnylam readout overdone, says JPMorgan 07/26/22 Piper Sandler BioMarin competitor BridgeBio data falls short, says Piper Sandler 03/16/22 H.C. Wainwright BridgeBio price target lowered to $22 from $24 at H.C. Wainwright 03/11/22 JPMorgan BridgeBio price target lowered to $18 from $21 at JPMorgan BBIO BridgeBio $11.91 / +0.745 (+6.67%) 08/04/22 BridgeBio reports Q2 EPS (7c), consensus (92c) 05/05/22 BridgeBio reports Q1 EPS ($1.35), consensus ($1.11) 02/24/22 BridgeBio reports Q4 EPS ($1.01), consensus (87c) BBIO BridgeBio $11.91 / +0.745 (+6.67%) 05/12/22 Fly Intel: Pre-market Movers 00:00 Today Biotechnology Conference 18:30 Today BridgeBio
Hot Stocks	Opiant Pharmaceuticals receives additional BARDA funding for OPNT003 » 17:52 08/08/22 08/08 17:52 08/08/22 17:52 OPNT Opiant Pharmaceuticals $11.83 / +0.46 (+4.05%) Opiant Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events OPNT Opiant Pharmaceuticals $11.83 / +0.46 (+4.05%) 06/08/22 Opiant expands collaboration with Aptar Pharma 06/01/22 Opiant begins rolling submission of NDA to FDA for opioid overdose treatment 05/13/22 Opiant Pharmaceuticals Inc trading resumes 05/13/22 Opiant Pharmaceuticals Inc trading halted, volatility trading pause OPNT Opiant Pharmaceuticals $11.83 / +0.46 (+4.05%) 04/28/22 Northland Northland sees 'major buying pportunity' as Opiant wraps OPNT003 clinical work 12/08/21 Oppenheimer Opiant Pharmaceuticals initiated with an Outperform at Oppenheimer OPNT Opiant Pharmaceuticals $11.83 / +0.46 (+4.05%) 05/10/22 Opiant Pharmaceuticals reports Q1 EPS ($2.43), consensus (91c) 03/15/22 Opiant Pharmaceuticals reports Q4 EPS 11c, consensus (1c) 08/11/22 Opiant Pharmaceuticals - OPNT
Hot Stocks	Enthusiast Gaming updates senior management team, names John Albright chairman » 17:51 08/08/22 08/08 17:51 08/08/22 17:51 EGLX Enthusiast Gaming $1.94 / +0.05 (+2.65%) Enthusiast Gaming… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research EGLX Enthusiast Gaming $1.94 / +0.05 (+2.65%) 07/07/22 Enthusiast Gaming to initiate search for new CEO following role switch 07/07/22 Enthusiast Gaming announces two nominees from Greywood Investments to join board 06/30/22 Enthusiast Gaming issued letter to shareholders 06/27/22 Greywood Investments issues letter to Enthusiast Gaming shareholders EGLX Enthusiast Gaming $1.94 / +0.05 (+2.65%) 07/19/22 B. Riley Enthusiast Gaming price target lowered to C$7.25 from C$11.50 at B. Riley 05/17/22 RBC Capital Enthusiast Gaming price target raised to C$8 from C$7 at RBC Capital 03/29/22 Scotiabank Enthusiast Gaming price target lowered to C$8 from C$8.25 at Scotiabank 03/24/22 Scotiabank Enthusiast Gaming price target lowered to C$8.25 from C$9.75 at Scotiabank

Periodicals	U.S. judge skeptical of Ben & Jerry's claims against Unilever, Reuters says » 17:49 08/08/22 08/08 17:49 08/08/22 17:49 UL Unilever $48.41 / +0.34 (+0.71%) , UN Use symbol UL $60.50 / + (+0.00%) U.S. District Judge… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events UL UN UL Unilever $48.41 / +0.34 (+0.71%) 07/20/22 Unilever Food Solutions U.S. recalls Knorr Professional Soup du Jour soup mix 06/29/22 Unilever sells Ben & Jerry's business interests in Israel to current licensee 06/29/22 Unilever expands partnership with Numerator 06/16/22 Unilever, Genomatica launch $120M JV for alternative to palm oil ingredients UN Use symbol UL $60.50 / + (+0.00%) 07/20/22 Unilever Food Solutions U.S. recalls Knorr Professional Soup du Jour soup mix 05/11/22 AXA, Unilever, Tikehau Capital sign MOU to create impact fund UL UN UL Unilever $48.41 / +0.34 (+0.71%) 07/27/22 DZ Bank Unilever downgraded to Hold from Buy at DZ Bank 07/26/22 Deutsche Bank Unilever upgraded at Deutsche Bank as commodity headwinds flip to tailwinds 07/26/22 Deutsche Bank Unilever upgraded to Buy from Hold at Deutsche Bank 07/22/22 Bernstein Unilever upgraded to Outperform from Market Perform at Bernstein UN Use symbol UL $60.50 / + (+0.00%) 01/17/22 Bernstein Unilever downgraded to Underperform from Market Perform at Bernstein 01/17/22 Barclays Unilever downgraded to Equal Weight from Overweight at Barclays 01/10/22 Citi Unilever resumed with a Buy at Citi 11/01/21 Bernstein Unilever upgraded to Market Perform from Underperform at Bernstein UL UL Unilever $48.41 / +0.34 (+0.71%) 07/26/22 Unilever raises 2022 sales growth view 07/26/22 Unilever reports Q1 EPS EUR1.34, up 1% y/y UL UN UL Unilever $48.41 / +0.34 (+0.71%) 08/03/22 Unilever ceases paying Ben & Jerry's independent board members, FT reports 08/01/22 Ben & Jerry's talks with Unilever over Israel unit sale break down, Reuters says 07/26/22 Unilever raised prices 11% in Q2, FT reports 07/05/22 Ben & Jerry's sues Unilever to block Israeli business sale, Reuters reports UN Use symbol UL $60.50 / + (+0.00%) 08/01/22 Ben & Jerry's talks with Unilever over Israel unit sale break down, Reuters says UL UL Unilever $48.41 / +0.34 (+0.71%) 07/22/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/31/22 What You Missed On Wall Street On Tuesday 05/31/22 What You Missed On Wall Street This Morning 05/31/22 Fly Intel: Pre-market Movers 09/19/22 Groceryshop
Hot Stocks	Clover Health CEO Vivek Garipalli to switch roles, Andrew Toy to succeed » 17:47 08/08/22 08/08 17:47 08/08/22 17:47 CLOV Clover Health $3.40 / +0.14 (+4.30%) , GOOG Alphabet $118.17 / -0.11 (-0.09%) , GOOGL Alphabet $117.32 / -0.17 (-0.14%) Clover Health (CLOV)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options CLOV GOOG GOOGL CLOV Clover Health $3.40 / +0.14 (+4.30%) 07/14/22 Clover Health announces planned medicare edvantage expansion for 2023 06/24/22 Clover Health is set to join the Russell 3000 Index 05/25/22 Clover Health appoints Scott Leffler as CFO 03/14/22 Clover Health appoints Joseph Martin as general counsel GOOG Alphabet $118.17 / -0.11 (-0.09%) 08/02/22 Mandiant to not provide guidance due to pending transaction with Google 08/02/22 Thryv and Google team to streamline communication for small businesses 07/31/22 Fly Intel: Top five weekend stock stories 07/29/22 Google says Stadia game streaming service not shutting down GOOGL Alphabet $117.32 / -0.17 (-0.14%) 08/02/22 Mandiant to not provide guidance due to pending transaction with Google 07/31/22 Fly Intel: Top five weekend stock stories 07/29/22 Google says Stadia game streaming service not shutting down 07/28/22 Google updates Play Store policies around intrusive advertisements CLOV GOOG GOOGL CLOV Clover Health $3.40 / +0.14 (+4.30%) 02/24/22 Canaccord Clover Health price target raised to $7 from $6 at Canaccord 02/17/22 Citi Citi opens 'negative catalyst watches' in health care services 02/02/22 Cowen Clover Health upgraded to Market Perform from Underperform at Cowen 01/19/22 SVB Leerink Clover Health initiated with a Market Perform at SVB Leerink GOOG Alphabet $118.17 / -0.11 (-0.09%) 08/03/22 Tigress Financial Alphabet price target raised to $186 from $183 at Tigress Financial 07/27/22 Truist Chrome cookie phase-out delay positive for Criteo, says Truist 07/27/22 KeyBanc Google's cookie phase-out delay not surprising, says KeyBanc 07/27/22 RBC Capital Google cookie phase-out delay adds another year of uncertainty, says RBC Capital GOOGL Alphabet $117.32 / -0.17 (-0.14%) 08/03/22 Tigress Financial Alphabet price target raised to $186 from $183 at Tigress Financial 07/27/22 Truist Chrome cookie phase-out delay positive for Criteo, says Truist 07/27/22 KeyBanc Google's cookie phase-out delay not surprising, says KeyBanc 07/27/22 RBC Capital Google cookie phase-out delay adds another year of uncertainty, says RBC Capital CLOV GOOG GOOGL CLOV Clover Health $3.40 / +0.14 (+4.30%) 17:16 Today Clover Health reports Q2 revenue $846.7M, consensus $814.62M 05/09/22 Clover Health reaffirms FY22 revenue view $3.0B-$3.4B, consensus $3.24B 05/09/22 Clover Health reports Q1 revenue $874.4M, consensus $787.41M 02/23/22 Clover Health sees FY22 revenue $3.0B-$3.4B, consensus $2.62B GOOG Alphabet $118.17 / -0.11 (-0.09%) 07/26/22 Alphabet reports Q2 EPS $1.21, consensus $1.30 07/26/22 Notable companies reporting after market close 04/26/22 Alphabet reports Q1 EPS $24.62, consensus $25.96 04/26/22 Notable companies reporting after market close GOOGL Alphabet $117.32 / -0.17 (-0.14%) 07/26/22 Alphabet reports Q2 EPS $1.21, consensus $1.30 07/26/22 Notable companies reporting after market close 04/26/22 Alphabet reports Q1 EPS $24.62, consensus $25.96 04/26/22 Notable companies reporting after market close 18 Nov GOOG GOOGL GOOG Alphabet $118.17 / -0.11 (-0.09%) 08:16 Today Google files two more patent lawsuits against Sonos, Bloomberg Law reports 08/04/22 EU antitrust enforcers to investigate Google Play Store rules, Politico reports 08/02/22 Rumble allowed to proceed with antitrust suit against Google, Verge reports 08/01/22 Amazon hires senior congressional aide to fight antitrust bill, Bloomberg says GOOGL Alphabet $117.32 / -0.17 (-0.14%) 08:16 Today Google files two more patent lawsuits against Sonos, Bloomberg Law reports 08/04/22 EU antitrust enforcers to investigate Google Play Store rules, Politico reports 08/02/22 Rumble allowed to proceed with antitrust suit against Google, Verge reports 08/01/22 Amazon hires senior congressional aide to fight antitrust bill, Bloomberg says CLOV GOOG GOOGL CLOV Clover Health $3.40 / +0.14 (+4.30%) 05/10/22 Fly Intel: Pre-market Movers 05/09/22 Fly Intel: After-Hours Movers 02/24/22 What You Missed On Wall Street On Thursday 02/24/22 What You Missed On Wall Street This Morning GOOG Alphabet $118.17 / -0.11 (-0.09%) 16:46 Today What You Missed On Wall Street On Monday 12:12 Today What You Missed On Wall Street This Morning 08/04/22 What You Missed On Wall Street This Morning 08/03/22 #SocialStocks: Five-day trial between Twitter and Elon Musk set for October 17 GOOGL Alphabet $117.32 / -0.17 (-0.14%) 16:46 Today What You Missed On Wall Street On Monday 12:12 Today What You Missed On Wall Street This Morning 08/04/22 What You Missed On Wall Street This Morning 08/03/22 #SocialStocks: Five-day trial between Twitter and Elon Musk set for October 17 17:00 Today Clover Health - CLOV CLOV GOOG GOOGL CLOV Clover Health $3.40 / +0.14 (+4.30%) 13:34 Today Clover Health options imply 12.4% move in share price post-earnings 07/18/22 Unusually active option classes on open July 18th 06/27/22 Unusually active option classes on open June 27th 06/21/22 Unusually active option classes on open June 21st GOOG Alphabet $118.17 / -0.11 (-0.09%) 07/26/22 Alphabet options imply 6.1% move in share price post-earnings 07/25/22 Unusually active option classes on open July 25th 07/25/22 Alphabet put buyer realizes 47% same-day gains 07/22/22 Unusually active option classes on open July 22nd GOOGL Alphabet $117.32 / -0.17 (-0.14%) 07/27/22 Notable open interest changes for July 27th 07/26/22 Alphabet Class A options imply 6.1% move in share price post-earnings 07/25/22 Unusually active option classes on open July 25th 07/22/22 Unusually active option classes on open July 22nd
Hot Stocks	Horizon Global announces review of strategic alternatives » 17:46 08/08/22 08/08 17:46 08/08/22 17:46 HZN Horizon Global $1.38 / +0.035 (+2.60%) Horizon Global announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Events HZN Horizon Global $1.38 / +0.035 (+2.60%) 07/29/22 Horizon Global addresses NYSE continued listing standards 06/29/22 Horizon Global appoints Jian James Zhou as CFO 06/08/22 Horizon Global and Continental settle patent dispute 02/14/22 Horizon Global rises 10.6% 08/09/22 Horizon Global - HZN
Earnings	Cara Therapeutics reports Q2 EPS (8c), consensus (25c) » 17:43 08/08/22 08/08 17:43 08/08/22 17:43 CARA Cara Therapeutics $11.50 / +0.215 (+1.91%) Reports Q2 revenue $23M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CARA Cara Therapeutics $11.50 / +0.215 (+1.91%) 06/30/22 Cara Therapeutics announces results from Phase 2 trial of difelikefalin 06/06/22 Amarin CFO Michael Kalb resigns, Tom Reilly to succeed 06/03/22 Cara Therapeutics CFO Thomas Reilly resigns, Richard Makara named interim CFO 04/28/22 Vifor Fresenius, Cara announces European Commission authorization for Kapruvia CARA Cara Therapeutics $11.50 / +0.215 (+1.91%) 05/10/22 H.C. Wainwright H.C. Wainwright sees 'major valuation disconnect' at Cara Therapeutics 03/14/22 Canaccord Cara Therapeutics price target lowered to $29 from $33 at Canaccord 03/08/22 JPMorgan Cara Therapeutics upgraded to Overweight from Neutral at JPMorgan 11/01/21 Canaccord Cara Therapeutics assumed with a Buy at Canaccord CARA Cara Therapeutics $11.50 / +0.215 (+1.91%) 05/09/22 Cara Therapeutics reports Q1 EPS (52c), consensus (54c) 03/01/22 Cara Therapeutics reports Q4 EPS (63c), consensus (52c) 00:00 Today 42nd Annual Global I Growth Conference 16:30 Today Cara Therapeutics - CARA
Earnings	Chimerix reports Q2 EPS (27c), consensus (24c) » 17:36 08/08/22 08/08 17:36 08/08/22 17:36 CMRX Chimerix $2.36 / -0.325 (-12.13%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events CMRX Chimerix $2.36 / -0.325 (-12.13%) 07:22 Today Chimerix appoints Jordan as VP, Regulatory Affairs 08/04/22 Siga, Chimerix rallyafter WaPo report of monkeypox emergency declaration 06/24/22 Chimerix announces $25.3M TEMBEXA procurement agreement 06/23/22 Chimerix announces $9.3M TEMBEXA procurement agreement CMRX Chimerix $2.36 / -0.325 (-12.13%) 05/20/22 Benchmark Benchmark says Emergent, Siga, Chimerix strength attributable to monkeypox scare 05/16/22 H.C. Wainwright Chimerix price target lowered to $11 from $24 at H.C. Wainwright 12/22/21 H.C. Wainwright Chimerix price target raised to $24 from $21 at H.C. Wainwright 11/22/21 H.C. Wainwright Chimerix price target raised to $21 from $19 at H.C. Wainwright CMRX Chimerix $2.36 / -0.325 (-12.13%) 05/16/22 Chimerix reports Q1 EPS (28c), consensus (33c) 03/01/22 Chimerix reports Q4 EPS (45c), consensus (17c) 15 Sep CMRX Chimerix $2.36 / -0.325 (-12.13%) 08/04/22 Biden to declare monkeypox public health emergency, Washington Post says 07/25/22 WHO declares monkeypox outbreak global health emergency, CNBC reports CMRX Chimerix $2.36 / -0.325 (-12.13%) 08/04/22 What You Missed On Wall Street On Thursday 07/25/22 These vaccine makers are jumping after monkeypox declared global emergency 05/27/22 As Monkeypox cases rise, so do shares of Siga 05/16/22 What You Missed On Wall Street On Monday 08/09/22 Wedbush PacGrow Healthcare Virtual Conference 16:30 Today Chimerix - CMRX
Hot Stocks	Ur-Energy signs agreement with U.S. nuclear utility » 17:35 08/08/22 08/08 17:35 08/08/22 17:35 URG Ur-Energy $1.18 / -0.01 (-0.84%) Ur-Energy announce that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Periodicals URG Ur-Energy $1.18 / -0.01 (-0.84%) 11/02/21 Alliance Global Partners Ur-Energy price target raised to $2.50 from $2.20 at Alliance Global Partners URG Ur-Energy $1.18 / -0.01 (-0.84%) 04/18/22 Energy Department set to announce $6B nuclear plant lifeline, Bloomberg says
Earnings	Mesa Air reports Q3 EPS (28c), consensus (22c) » 17:34 08/08/22 08/08 17:34 08/08/22 17:34 MESA Mesa Air $2.66 / +0.135 (+5.35%) Reports Q3 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events MESA Mesa Air $2.66 / +0.135 (+5.35%) 06/08/22 Mesa Air announces enhanced United Aviate partnership 04/22/22 Mesa Air appoints Amy Krallman as VP, human resources 03/01/22 Mesa Air appoints Christian Daoud as VP, maintenance and technical operations MESA Mesa Air $2.66 / +0.135 (+5.35%) 05/11/22 Deutsche Bank Mesa Air price target lowered to $3 from $5.50 at Deutsche Bank 02/04/22 Raymond James Mesa Air downgraded to Market Perform from Outperform at Raymond James 02/04/22 Raymond James Mesa Air downgraded to Market Perform from Outperform at Raymond James 01/07/22 BofA Mesa Air downgraded to Neutral from Buy at BofA MESA Mesa Air $2.66 / +0.135 (+5.35%) 05/09/22 Mesa Air reports Q2 EPS ( 29c), consensus (31c) 02/09/22 Mesa Air reports Q EPS (26c), consensus (12c) 16:30 Today Mesa Air - MESA
Hot Stocks	National Healthcare announces $25M stock repurchase authorization » 17:31 08/08/22 08/08 17:31 08/08/22 17:31 NHC National Healthcare $69.31 / +1.14 (+1.67%) National HealthCare… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings NHC National Healthcare $69.31 / +1.14 (+1.67%) 05/05/22 National Healthcare raises quarterly dividend by 3.6% to 57c per share NHC National Healthcare $69.31 / +1.14 (+1.67%) 02/18/22 National Healthcare reports Q4 adjusted EPS $1.02 vs. 90c last year
Hot Stocks	CorMedix receives CRL from FDA saying that DefenCath NDA cannot be approved » 17:31 08/08/22 08/08 17:31 08/08/22 17:31 CRMD CorMedix $7.50 / +0.39 (+5.49%) CorMedix announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings On The Fly Events CRMD CorMedix $7.50 / +0.39 (+5.49%) 05/12/22 CorMedix believes it has sufficient resources to fund through 1H of 2023 05/12/22 CorMedix announces leadership updates, operational changes 04/07/22 CorMedix announces SAB to support commercialization, pipeline development 03/28/22 CorMedix announces FDA acceptance of resubmission of NDA for DefenCath CRMD CorMedix $7.50 / +0.39 (+5.49%) 05/12/22 CorMedix reports Q1 EPS (18c), consensus (22c) 03/29/22 CorMedix reports Q4 EPS (20c), consensus (23c) CRMD CorMedix $7.50 / +0.39 (+5.49%) 03/29/22 Fly Intel: After-Hours Movers 08/11/22 CorMedix - CRMD
Syndicate	Cyteir Therapeutics files $300M mixed securities shelf 17:30 08/08/22 08/08 17:30 08/08/22 17:30 CYT Cyteir Therapeutics $2.58 / +0.09 (+3.61%) ShowHide Related Items >><< Company News Street Research Earnings Events CYT Cyteir Therapeutics $2.58 / +0.09 (+3.61%) 16:08 Today Cyteir Therapeutics expects cash to fund operations into second half of 2024 06/05/22 Cyteir Therapeutics presents CYT-0851 Phase 1 dose escalation results 04/25/22 Cyteir Therapeutics appoints Adam Veness as general counsel CYT Cyteir Therapeutics $2.58 / +0.09 (+3.61%) 03/17/22 Wedbush Cyteir Therapeutics price target lowered to $30 from $40 at Wedbush 02/07/22 Northland Cyteir Therapeutics initiated with an Outperform at Northland CYT Cyteir Therapeutics $2.58 / +0.09 (+3.61%) 16:08 Today Cyteir Therapeutics reports Q2 EPS (34c), consensus (44c) 05/05/22 Cyteir Therapeutics reports Q1 EPS (40c), consensus (39c) 03/16/22 Cyteir Therapeutics reports Q4 EPS (34c), consensus (39c) 00:00 Today Biotechnology Conference 08/09/22 Wedbush PacGrow Healthcare Virtual Conference

Syndicate	Biolase files to sell 1.41M shares of common stock for holders 17:30 08/08/22 08/08 17:30 08/08/22 17:30 BIOL Biolase $5.40 / +0.12 (+2.27%) ShowHide Related Items >><< Company News Street Research Earnings Events BIOL Biolase $5.40 / +0.12 (+2.27%) 07/25/22 Biolase receives five new United States patents, seven new foreign patents 07/13/22 Biolase announces pilot program with Einstein Healthcare Network's residency 07/07/22 Biolase promotes Jennifer Bright to CFO, Steven Sandor to COO 07/05/22 Biolase announces partnership with TeamSmile BIOL Biolase $5.40 / +0.12 (+2.27%) 05/20/22 Lake Street Biolase initiated with a Buy at Lake Street 08/19/21 Ascendiant Biolase price target raised to $3 from $2 at Ascendiant BIOL Biolase $5.40 / +0.12 (+2.27%) 05/12/22 Biolase sees Q2 revenue above $10.5M, consensus $10.2M 05/12/22 Biolase reports Q1 EPS (77c), consensus (68c) 08/11/22 Biolase - BIOL
Syndicate	CinCor Pharma files to sell 6M shares of common stock, pre-funded warrants » 17:29 08/08/22 08/08 17:29 08/08/22 17:29 CINC CinCor Pharma $34.96 / +11.46 (+48.77%) Goldman Sachs & Co.,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options CINC CinCor Pharma $34.96 / +11.46 (+48.77%) 07:24 Today CinCor Pharma announces data for Phase 2 BrigHtn trial evaluating baxdrostat 07:21 Today CinCor Pharma announces upcoming milestones 07/26/22 CinCor Pharma announces last patient randomized in Phase 2 HALO trial 06/01/22 CinCor Pharma doses first patient in Phase 2 figHTN-CKD trial CINC CinCor Pharma $34.96 / +11.46 (+48.77%) 14:35 Today Oppenheimer CinCor Pharma price target raised to $60 from $35 at Oppenheimer 07/21/22 Oppenheimer CinCor Pharma price target raised to $35 from $30 at Oppenheimer 02/01/22 Oppenheimer CinCor Pharma initiated with an Outperform at Oppenheimer 02/01/22 Evercore ISI CinCor Pharma initiated with an Outperform at Evercore ISI CINC CinCor Pharma $34.96 / +11.46 (+48.77%) 07:20 Today CinCor Pharma reports Q2 EPS (56c), consensus (50c) 05/10/22 CinCor Pharma reports Q1 EPS (50c), consensus (50c) 03/22/22 CinCor Pharma reports Q4 EPS ($15.71) vs. ($4.65) last year 07 Jan CINC CinCor Pharma $34.96 / +11.46 (+48.77%) 16:46 Today What You Missed On Wall Street On Monday 12:12 Today What You Missed On Wall Street This Morning 03/26/22 Opening Day: AN2 Therapeutics rises in public debut after upsized IPO 08:30 Today CinCor Pharma - CINC CINC CinCor Pharma $34.96 / +11.46 (+48.77%) 07/13/22 Two new option listings on July 13th
Earnings	Primoris reports Q2 adjusted EPS 48c, two estimates 59c » 17:29 08/08/22 08/08 17:29 08/08/22 17:29 PRIM Primoris $22.52 / +0.095 (+0.42%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events PRIM Primoris $22.52 / +0.095 (+0.42%) 07/05/22 Primoris awarded contract at over $170M 06/27/22 Primoris enter agreement to acquire PLH in all-cash transaction valued at $470M 06/23/22 Primoris awarded $260M solar project 05/06/22 Primoris awarded $130M solar project PRIM Primoris $22.52 / +0.095 (+0.42%) 11/10/21 Goldman Sachs Goldman downgrades Primoris to Sell on 'bottom quintile' growth 11/10/21 Goldman Sachs Primoris downgraded to Sell from Neutral at Goldman Sachs PRIM Primoris $22.52 / +0.095 (+0.42%) 05/09/22 Primoris raises FY22 adjusted EPS view to $2.49-$2.69 from $2.39-$2.59 05/09/22 Primoris reports Q1 adjusted EPS 1c, consensus 9c 02/28/22 Primoris sees FY22 EPS $2.39-$2.59, consensus $2.50 02/28/22 Primoris reports Q4 EPS 63c, consensus 56c 08/09/22 Primoris - PRIM
Syndicate	Merchants Bancorp files $500M mixed securities shelf 17:27 08/08/22 08/08 17:27 08/08/22 17:27 MBIN Merchants Bancorp $27.72 / +0.445 (+1.63%) ShowHide Related Items >><< Company News Earnings MBIN Merchants Bancorp $27.72 / +0.445 (+1.63%) 02/17/22 Merchants Bancorp raises quarterly dividend 17% to 7c from 6c per share MBIN Merchants Bancorp $27.72 / +0.445 (+1.63%) 04/28/22 Merchants Bancorp reports Q1 EPS $1.02, consensus $1.00
Earnings	Freshpet backs FY22 revenue view of at least $575M, consensus $582.72M » 17:27 08/08/22 08/08 17:27 08/08/22 17:27 FRPT Freshpet $56.39 / +1.895 (+3.48%) Sees FY22 adjusted EBITDA… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events FRPT Freshpet $56.39 / +1.895 (+3.48%) 06/22/22 Freshpet recalls select product due to potential Salmonella contamination FRPT Freshpet $56.39 / +1.895 (+3.48%) 05/20/22 Atlantic Equities Atlantic Equities sees more volatility for Freshpet, downgrades shares 05/20/22 Atlantic Equities Freshpet downgraded to Neutral from Overweight at Atlantic Equities 05/03/22 Cowen Freshpet price target lowered to $163 from $181 at Cowen 05/03/22 Oppenheimer Freshpet price target lowered to $110 from $120 at Oppenheimer FRPT Freshpet $56.39 / +1.895 (+3.48%) 17:25 Today Freshpet reports Q2 EPS (45c), consensus (14c) 05/02/22 Freshpet backs FY22 revenue view at least $575M, consensus $576.99M 05/02/22 Freshpet reports Q1 EPS (40c), consensus (39c) 02/28/22 Freshpet sees FY22 revenue $575M, consensus $562.4M 04 May FRPT Freshpet $56.39 / +1.895 (+3.48%) 05/20/22 Proven algorithm says sell these stocks now 05/20/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/13/22 Short Report: Upstart shorts take profits as stock craters on guidance cut 05/13/22 Proven algorithm says sell these stocks now 16:30 Today Freshpet - FRPT 08/11/22 Freshpet

Events

Earnings calls, analyst events, roadshows and more

YALA
Today at 20:00

Yalla - YALA Conference Calls
Tomorrow at 00:00

E&P Meeting Circuit--Dingmann Conferences

Denver, CO
AVID ...
Tomorrow at 00:00

25th Annual Technology, Internet & Communications Virtual Conference Conferences

Virtual Conference
SYNA ...
Tomorrow at 00:00

23rd Annual Technology Leadership Forum Conferences

Vail, CO
Tomorrow at 00:00

Hot Wheels Bus Tour Conferences

New York/New Jersey
MTZ ...
Tomorrow at 00:00

8th Annual Communications Infrastructure Summit Conferences

Boulder, CO
Tomorrow at 00:00

7th Annual Wells Fargo FinTech & Technology Services Forum Conferences

Gurney's Newport Beach, Newport, RI
ORGN ...
Tomorrow at 00:00

SMID Cap Ideas Virtual Conference Conferences

Virtual Conference
Tomorrow at 00:00

10th Annual Internet & Media Bus Tour Conferences

San Francisco, CA
SI ...
Tomorrow at 00:00

42nd Annual Global I Growth Conference Conferences

Boston, MA

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	NUZE X NUZE NuZee Spot Secondary Managers: Maxim Priced at: $0.82 4.2M Shares
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	AYTU X AYTU Aytu BioPharma Spot Secondary Managers: Cantor Fitzgerald & Canaccord $0.59 MDNA X MDNA Medicenna Therapeutics Spot Secondary Managers: Guggenheim, Bloom Burton Securities $1.45-1.55 PFLT X PFLT PennantPark Floating Rate Spot Secondary Managers: Morgan Stanley, Goldman Sachs, JPMorgan, Keefe Bruyette, RBC Capital & Truist $12.40-12.70
Tues	KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan, Jefferies $241.19 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	FRZA X FRZA Forza X1 IPO Managers: ThinkEquity $5.00 3M Shares PTLO X PTLO Portillo's Secondary Managers: Jefferies & Morgan Stanley, BofA, Piper Sandler $28.44 8M Shares SOVO X SOVO Sovos Brands Secondary Managers: JPMorgan & Goldman Sachs, BofA, Credit Suisse, Barclays, UBS, Cowen, Piper Sandler, Stifel, William Blair, Telsey Advisory, Drexel Hamilton, Loop Capital $16.01 8.5M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Science 37 backs 2022 revenue view $86M-$96M, consensus $91.13M

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access